According to Perrigo's latest financial reports the company's total debt is $4.07 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $4.07 B | -0.81% |
2022-12-31 | $4.10 B | 11.18% |
2021-12-31 | $3.69 B | -0.86% |
2020-12-31 | $3.72 B | 10.58% |
2019-12-31 | $3.36 B | 3.91% |
2018-12-31 | $3.24 B | -2.96% |
2017-12-31 | $3.34 B | -42.37% |
2016-12-31 | $5.79 B | |
2015-06-30 | $5.40 B | 68.4% |
2014-06-30 | $3.20 B | 62.45% |
2013-06-30 | $1.97 B | 44.16% |
2012-06-30 | $1.36 B | 53.38% |
2011-06-30 | $0.89 B | -33.57% |
2010-06-30 | $1.34 B | 50.64% |
2009-06-30 | $0.89 B | -2.51% |
2008-06-30 | $0.91 B | 35% |
2007-06-30 | $0.67 B | 5.63% |
2006-06-30 | $0.64 B | -5.82% |
2005-06-30 | $0.68 B | 7052.32% |
2004-06-30 | $9.52 M | 6.1% |
2003-06-30 | $8.98 M | 7.7% |
2002-06-30 | $8.33 M | -34.65% |
2001-06-30 | $12.75 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | $0.70 B | -82.82% | ๐บ๐ธ USA |
Endo International
ENDPQ | $5.08 M | -99.88% | ๐ฎ๐ช Ireland |
Intercept Pharmaceuticals
ICPT | $0.22 B | -94.50% | ๐บ๐ธ USA |
Catalent CTLT | $5.01 B | 23.09% | ๐บ๐ธ USA |